{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:13:07Z","timestamp":1761664387928,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.lungcan.2022.03.001","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T10:54:21Z","timestamp":1646477661000},"page":"132-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Osimertinib-induced syndrome of inappropriate secretion of antidiuretic hormone in oncogene-addicted lung adenocarcinoma: A case report"],"prefix":"10.1016","volume":"166","author":[{"given":"Marcus","family":"Skribek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedek","family":"Bozoky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Tsakonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lungcan.2022.03.001_b0005","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1470-2045(09)70110-X","article-title":"EGFR testing in lung cancer is ready for prime time","volume":"10","author":"Hirsch","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lungcan.2022.03.001_b0010","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.lungcan.2022.03.001_b0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.ajkd.2011.08.029","article-title":"Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes","volume":"59","author":"Doshi","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.lungcan.2022.03.001_b0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2016.02.064","article-title":"Electrolyte disorders associated with the use of anticancer drugs","volume":"777","author":"Liamis","year":"2016","journal-title":"European Journal of Pharmacology"},{"issue":"12","key":"10.1016\/j.lungcan.2022.03.001_b0025","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1345\/aph.1L410","article-title":"Syndrome of Inappropriate Secretion of Antidiuretic Hormone Associated with Imatinib","volume":"42","author":"Liapis","year":"2008","journal-title":"Annals of Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.lungcan.2022.03.001_b0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0301-0082(99)00071-4","article-title":"Osmotic regulation of neuronal activity: a new role for taurine and glial cells in a hypothalamic neuroendocrine structure","volume":"62","author":"Hussy","year":"2000","journal-title":"Prog Neurobiol"},{"issue":"18","key":"10.1016\/j.lungcan.2022.03.001_b0035","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.1523\/JNEUROSCI.21-18-07110.2001","article-title":"Osmoregulation of vasopressin secretion via activation of neurohypophysial nerve terminals glycine receptors by glial taurine","volume":"21","author":"Hussy","year":"2001","journal-title":"J Neurosci"},{"issue":"27","key":"10.1016\/j.lungcan.2022.03.001_b0040","doi-asserted-by":"crossref","first-page":"19919","DOI":"10.1016\/S0021-9258(20)80672-3","article-title":"Protein tyrosine phosphorylation is involved in osmoregulation of ionic conductances","volume":"268","author":"Tilly","year":"1993","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.lungcan.2022.03.001_b0045","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/1078155220942302","article-title":"Gefitinib induced severe hyponatremia: A case report","volume":"27","author":"Meena","year":"2021","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"10.1016\/j.lungcan.2022.03.001_b0050","doi-asserted-by":"crossref","first-page":"e784","DOI":"10.1016\/j.cllc.2021.03.003","article-title":"Osimertinib-induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone","volume":"22","author":"Takao","year":"2021","journal-title":"Clinical Lung Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222003701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222003701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:01:30Z","timestamp":1759237290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500222003701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":10,"alternative-id":["S0169500222003701"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.03.001","relation":{},"ISSN":["0169-5002"],"issn-type":[{"type":"print","value":"0169-5002"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osimertinib-induced syndrome of inappropriate secretion of antidiuretic hormone in oncogene-addicted lung adenocarcinoma: A case report","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}